Life stressors, mastery, and perceived partner engagement in HIV-Risk behavior.
RISK-taking behavior; AFRICAN Americans; ETHNIC groups; EUROPEAN Americans; HIV infections; HUMAN sexuality; MAN-woman relationships; PHYSIOLOGICAL stress
The relationships among level of personal mastery, economic stress, number of sexual partners, pregnancy status, and perceived partner engagement in HIV-risk behaviors (i.e., intravenous drug use, imprisonment, and sex with other partners) were studied in a sample of 1069 single, inner-city women. African American and European Americans were equally represented. We predicted that greater economic stress, a lower sense of personal mastery, and more sexual partners would be associated with greater perceptions of partner engagement in HIV-risk behavior. We also predicted that personal mastery would serve as a moderating variable in the presence of life stressors (e.g., being pregnant, having multiple sexual partners). The findings supported the hypotheses. Women with more economic stress, multiple sexual partners, and lower personal mastery reported higher perceived partner engagement in HIV-risk behavior than women with lower economic stress, one sexual partner, and higher personal mastery. Personal mastery had a greater impact for women with multiple sexual partners and for those who were pregnant. These findings were qualified by women's ethnicity. © 2001 John Wiley & Sons, Inc. [ABSTRACT FROM AUTHOR]
Jackson Tomara D; Hobfoll Stevan E; Jackson Anita P; Lavin Justin
Journal of Community Psychology
2001
2001-01
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1002/1520-6629(200101)29:1" target="_blank" rel="noreferrer noopener">10.1002/1520-6629(200101)29:1<1::aid-jcop1>3.0.co;2-n</a>
Addressing Decision Making in Progesterone Treatment for History of Preterm Delivery
17-OHP; decision; preterm birth; progesterone; qualitative
Introduction The United States ranks 27th among nations worldwide for infant mortality with a rate of 6.1 deaths per 1,000 live births. The majority of perinatal morbidity and mortality is related to preterm birth, defined as delivery prior to 37 weeks' gestation. Among the risk factors for preterm birth is prior preterm birth, which is associated with a 1.5- to 2.0-fold increase in risk. At the present time, there is only one Food and Drug Administration approved treatment for the prevention of preterm birth among women with a history of prior spontaneous premature delivery, intramuscular 17-α-hydroxyprogesterone caproate (17-OHP), administered once weekly from 20 to 36 weeks' gestation. However, many eligible pregnant patients decline this therapy. Methods This was a prospective, cohort study involving patients who were identified as candidates for 17-OHP treatment at their first obstetric visit and asked to complete a short survey regarding their history of preterm birth. Those patients who consented to a follow-up phone call were asked to participate in a focus group discussion regarding their experience with progesterone and the health care system. Results During the 1-year study period, 55 progesterone candidates were identified, 43 accepted treatment, 7 refused, and 5 either initiated prenatal care too late to receive injections or did not follow-up. Those who accepted treatment appeared to cope better with treatment side effects, and/or had traumatic emotional reactions regarding their prior premature birth outcomes. Women who declined treatment often cited pain with injection, had fatalistic beliefs regarding their care, and/or had personal concerns related to full-term pregnancy. Discussion Maternal health care providers should always discuss the implications of prematurity at the time of the index premature delivery and again at the first prenatal visit of the subsequent pregnancy. Providers need to be prepared to employ various techniques for patient counseling and education. Small changes in office practice, like having fewer care providers involved in patient care or providing distractions for children, may make the difference between a patient who is open or closed to treatment options.
Zuponcic Jacqueline; Cottrell Connie; Lavin Justin; Facchini Wendy; Li Marissa
AJP reports
2019
2019-07
<a href="http://doi.org/10.1055/s-0039-1688776" target="_blank" rel="noreferrer noopener">10.1055/s-0039-1688776</a>